KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesOther Gross PP&E AdjustmentsShares IssuedShares Outstanding
Ratios

Esperion Therapeutics (ESPR) Long-Term Debt Repayments (2018)

Historic Long-Term Debt Repayments for Esperion Therapeutics (ESPR) over the last 1 years, with Q3 2018 value amounting to $153000.0.

  • Esperion Therapeutics' Long-Term Debt Repayments changed N/A to $153000.0 in Q3 2018 from the same period last year, while for Dec 2018 it was $1.0 million, marking a year-over-year change of. This contributed to the annual value of $210.1 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Esperion Therapeutics reported Long-Term Debt Repayments of $153000.0 as of Q3 2018.
  • In the past 5 years, Esperion Therapeutics' Long-Term Debt Repayments ranged from a high of $451000.0 in Q2 2018 and a low of $153000.0 during Q3 2018